VOLIBO 0.2 MG (Voglibose (0.2mg))

Volibo 0.2 mg Tablet is prescribed for the management of type 2 diabetes mellitus. Its primary function is to aid in regulating elevated blood sugar levels that may occur after meals, particularly in patients for whom other medications, along with dietary changes, have proven insufficient. This medication is typically taken shortly before eating, and your healthcare provider will determine the appropriate dosage and frequency to ensure effective glucose control. It is important to discuss any discontinuation of this medication with your healthcare professional, as abrupt cessation could lead to a rise in blood sugar levels, increasing the risk of severe complications such as kidney impairment and vision loss. Volibo 0.2 mg is intended to be part of a comprehensive treatment strategy that encompasses a balanced diet, regular physical activity, and weight management, as recommended by your healthcare provider. Regular blood sugar monitoring is advised while on this medication. Some individuals may experience side effects, including gas, stomach discomfort, appetite reduction, constipation, and diarrhea. Should these issues persist or become troublesome, it is crucial to consult your healthcare provider. Although Volibo 0.2 mg alone is not known to cause low blood sugar, it can contribute to hypoglycemia when used in conjunction with other diabetes medications like insulin. In such cases, hypoglycemic episodes should be managed by administering glucose, as standard table sugar may not be effective. Prior to initiation, it is essential to inform your doctor of any existing kidney or liver conditions, as well as any medications you are currently taking. Pregnant or nursing individuals should seek medical advice before starting this drug. High alcohol consumption should be avoided, as it may heighten the risk of low blood sugar events.